Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1C72G | ISIN: BMG8162K1137 | Ticker-Symbol: TEL1
Frankfurt
01.11.24
08:04 Uhr
0,080 Euro
-0,003
-3,03 %
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD Chart 1 Jahr
5-Tage-Chart
SIHUAN PHARMACEUTICAL HOLDINGS GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,0790,09513:02
0,0790,09501.11.

Aktuelle News zur SIHUAN PHARMACEUTICAL HOLDINGS GROUP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
07.10.SIHUAN PHARM Leapfrogs 42% Once after Planning Buyback of $500M Max. Shrs3
07.10.listed Sihuan Pharma gains over 40% on share buyback plan1
27.09.Dividendenbekanntmachungen (27.09.2024)11.065 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABRDN EUROPEAN LOGISTICS INCOME PLC  GB00BD9PXH49  0,0077 GBP   EUR  ACADIAN TIMBER CORP  CA0042721005  0,29 CAD  0,1926 EUR  ACOM CO LTD  JP3108600002  7...
► Artikel lesen
27.09.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-EXCLUSIVE DISTRIBUTION AGREEMENT FOR BOTUNLINUM TOXIN LETYBO RENEWED UNTIL END OF THE YEAR 20305
23.09.SIHUAN PHARM (00460): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER-
23.09.SIHUAN PHARM (00460): NOTIFICATION LETTER AND CHANGE REQUEST FORM TO REGISTERED SHAREHOLDER-
23.09.SIHUAN PHARM (00460): INTERIM REPORT 20241
30.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-SEMAGLUTIDE INJECTION DEVELOPED BY HUISHENG BIOPHARMACEUTICAL FOR WEIGHT LOSS INDICATION OBTAINED IND APPROVAL ...1
30.08.SIHUAN PHARM (00460): INTERIM CASH DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 20242
30.08.SIHUAN PHARM (00460): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 20241
21.08.EQS Newswire: Sihuan Pharmaceutical Holdings Group: Sihuan Pharmaceutical (00460.HK): Subsidiary Huisheng Biopharmaceutical Reshapes Diabetes Treatment Landscape With Two Home-Grown Insulin Products342EQS Newswire / 21/08/2024 / 10:07 UTC+8 1. With Two Home-Grown Insulin Products Approved for Marketing, It Leads the Development of The Domestic Insulin MarketOn August 6th, Sihuan Pharmaceutical...
► Artikel lesen
20.08.SIHUAN PHARM (00460): NOTICE OF BOARD MEETING-
14.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-INSULIN DEGLUDEC INJECTION HUIYOUDA DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL ...1
12.08.EQS Newswire: Sihuan Pharmaceutical Holdings Group: Chinese Self-Developed IDegAsp Debuts! Huisheng Pharm Strives To Be Diabetes Drug Bellwether With Blockbuster Drugs in Going Global275EQS Newswire / 12/08/2024 / 14:52 UTC+8 1.Promising future growth of Huisheng with the launch of IDegAsp On the noon of August 6th, Sihuan Pharmaceutical Holdings Group (00460. HK) (thereafter...
► Artikel lesen
06.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-BLOCKBUSTER PRODUCT INSULIN DEGLUDEC AND INSULIN ASPART INJECTION HUIYOUJIA DEVELOPED BY HUISHENG BIOPHARMACEUTICAL ...2
06.08.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-SIHUAN PHARMACEUTICAL REACHED EXCLUSIVE DISTRIBUTION AGREEMENT IN RELATION TO CARTIZOL, AN INTRA-ARTICULAR ...1
27.06.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-CALCIUM DOBESILATE CAPSULES DEVELOPED BY HUISHENG BIOPHARMACEUTICAL OBTAINED DRUG REGISTRATION APPROVAL FROM ...1
26.06.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT-TICAGRELOR ORODISPERSIBLE TABLET OBTAINED DRUG REGISTRATION APPROVAL FROM NMPA2
24.06.SIHUAN PHARM (00460): NEXT DAY DISCLOSURE RETURN1
18.06.SIHUAN PHARM (00460): VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE SHARE AWARD SCHEME1
Seite:  Weiter >>
26 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1